<bill session="115" type="s" number="3711" updated="2019-07-19T21:27:29Z">
  <state datetime="2018-12-05">REFERRED</state>
  <status>
    <introduced datetime="2018-12-05"/>
  </status>
  <introduced datetime="2018-12-05"/>
  <titles>
    <title type="official" as="introduced">A bill to establish an annual fee applicable to opioid manufacturers.</title>
    <title type="short" as="introduced">Opioid Treatment Surge Act</title>
    <title type="short" as="introduced">Opioid Treatment Surge Act</title>
    <title type="display">Opioid Treatment Surge Act</title>
  </titles>
  <sponsor bioguide_id="M001176"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-12-05">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-12-05" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2018-12-05T05:00:00Z" status="Introduced in Senate">Opioid Treatment Surge Act

This bill establishes a retroactive annual fee for opioid manufacturers, based on the manufacturer's share of the opioid drug market.</summary>
  <committee-reports/>
</bill>
